Pregabalin In Adolescent Patients With Fibromyalgia
Status:
Completed
Trial end date:
2015-06-01
Target enrollment:
Participant gender:
Summary
The main purpose of this study is to evaluate the long-term safety of pregabalin in
adolescent patients who participated in the previous fibromyalgia study (A0081180) and who
wish to recieve open-label pregabalin
Phase:
Phase 4
Details
Lead Sponsor:
Pfizer Pfizer's Upjohn has merged with Mylan to form Viatris Inc.